28 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.
Bar-Ilan University
Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonists.
Bar-Ilan University
2-Hexylthio-ß,¿-CH2-ATP is an effective and selective NTPDase2 inhibitor.
Bar-Ilan University
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(a or¿)-thio-(a,ß- orß,¿)-methylenetriphosphate scaffold.
Bar-Ilan University
Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages.
Bar-Ilan University
Synthesis and mechanism of hypoglycemic activity of benzothiazole derivatives.
Bar-Ilan University
Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists.
Bar-Ilan University
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
Bar-Ilan University
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
Bar-Ilan University
Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.
Bar-Ilan University
Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors.
Bar-Ilan University
Identification of hydrolytically stable and selective P2Y(1) receptor agonists.
Bar-Ilan University
Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
Bar-Ilan University
Molecular recognition in purinergic receptors. 2. Diastereoselectivity of the h-P2Y1-receptor.
Bar-Ilan University
Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
Bar-Ilan University
Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.
Bar-Ilan University
2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors.
Bar-Ilan University
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
Bar-Ilan University
Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
Bar-Ilan University
2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.
Bar-Ilan University
A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.
Bar-Ilan University
Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.
Bar-Ilan University
Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy.
Bar-Ilan University
Development of chiral fluorinated alkyl derivatives of emixustat as drug candidates for the treatment of retinal degenerative diseases.
Bar-Ilan University
Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold.
Bar-Ilan University
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
Bar-Ilan University
